Therapeutic base editing to generate a gain-of-function F9 variant for hemophilia B

This study investigates the use of cytidine base editing to introduce the R338Q gain-of-function variant into the human F9 gene. Amplicon sequencing was performed to quantify on-target editing efficiency and evaluate potential bystander mutations, and GUIDE-seq was used to identify genome-wide off-target sites.